Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03387267 · ClinicalTrials.gov registry record · NA
Videofluoroscopic Swallowing Study (VFSS)
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Terminated
- Registry status
- NA
- Development phase
- 452
- Enrollment target
NCT03387267: Clinical Trial NA study, sponsored by Société des Produits Nestlé (SPN).
NCT03387267 is a NA study that was terminated before completion, run by Société des Produits Nestlé (SPN). The registered enrollment target is 452 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03387267, a NA study, was terminated before completion, sponsored by Société des Produits Nestlé (SPN).
- TERMINATED
- Registry status
- NA
- Development phase
- 452 participants
- Enrollment target
Study Summary
The study procedure of simultaneous VFSS and DDS measurement will be completed in one day and the subject will be followed within 2 business days after the study procedure to monitor for adverse events.
Primary Outcome
The primary efficacy of the DDS was measured as the sensitivity \& specificity obtained from comparing the DDS predicted swallow safety outcome (binary) with the clinical reference standard VFSS swallow safety outcome (binary) for thin barium (THIN-Ba) stimuli, using 5 boluses per subject protocol. ROC (AUC) was used for comparing the 2 algorithms. The ROC curve incorporates both sensitivity (true positive rate) and specificity (true negative rate) providing a single assessment incorporating bo
Interventions
- DEVICE Dysphagia Detection System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2017-10-24 |
| Est. Completion | 2018-07-23 |
| Phase | NA |
Why NCT03387267 stopped before completion
NCT03387267 is an interventional study that assigns participants to a tested intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 1 intervention - of which Dysphagia Detection System is the first listed.
NCT03387267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03387267 about?
NCT03387267 is a clinical study titled "Videofluoroscopic Swallowing Study (VFSS)". The study procedure of simultaneous VFSS and DDS measurement will be completed in one day and the subject will be followed within 2 business days after the study procedure to monitor for adverse events.
What is the current status of trial NCT03387267?
This trial is currently terminated. It is a NA study. The enrollment target is 452 participants. The study started on 2017-10-24. Estimated completion is 2018-07-23.
What interventions are being tested in trial NCT03387267?
The interventions under investigation include: Dysphagia Detection System (DEVICE).
Who is sponsoring clinical trial NCT03387267?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03387267's enrollment target sits among peer trials
452 225th of 2000 higher than 1,776 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT03460977 · 453 participants · Phase 1
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NCT04708171 · 453 participants
The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI